Skip to content

Tuesday, September 27, 2022

Latest:

A global collaboration to map the whole human brain
Be good to your gut: managing food intolerance
Celebrating advanced practice providers week
Reflections from a clinical ethics intern
National Postdoc Appreciation Week 2022

Baylor College of Medicine Blog Network

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

androgen receptor

Targeting MAPK4 emerges as a promising therapy for prostate cancer

February 23, 2021February 23, 2021Akt pathway, androgen receptor, cancer therapy, castration-resistant prostate cancer, MAPK4, Prostate Cancer, Research

Inhibiting MAPK4 simultaneously inactivated both androgen receptor and AKT and stopped cancer growth in animal models.

The N-terminal domain of the androgen receptor is at the heart of its action

July 30, 2020July 30, 2020androgen receptor, C-terminal domain, coactivators, n-terminal domain, Prostate Cancer, Research, testosterone

Detailed 3-D studies reveal how the androgen receptor is put together as a functional complex that drives prostate cancer.

From the Labs Video of the Month

From the Labs: RAIN-STORM 3D neuronal nanoscopic imaging

Healthy Habits: A DOC-umentary Series

Archives

Archives

Search

©1998 - 2020 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951